ROCKVILLE, MD, October 6, 2008 – Ariadne today announced that World Fusion has become Ariadne’s exclusive distributor in Japan, and will serve as support center for its patent-pending MedScan® technology and Pathway Studio® product line. Powered by MedScan technology, Pathway Studio enables scientists to control vast amounts of publicly available information and supplements all stages of research, from preparing grant and IND applications, through experimental planning, to the analysis and interpretation of experimental results.

“Our customers have been using Pathway Studio in different fields: RNAi, target and biomarker discovery, disease mechanism research, and many others to organize published information and use it to supplement experimental work and validate hypotheses”, said Kozo Kawahara, President of World Fusion. “Our corporate clients prefer Ariadne’s Pathway Studio for its unique data content and advanced data management capability”.

“World Fusion has been successfully reselling Ariadne’s products to Japanese biotechnology and pharmaceutical companies for over four years”, said Ilya Mazo, President of Ariadne. “Now with Pathway Studio version 6, our new generation product specifically designed for ease of use and powerful experimental data analysis capability, we expect World Fusion will expand to the academic market and will be successful as exclusive distributor”.